Loss of FMRP has been associated with disrupted lipid metabolism, including reduced circulating lipid levels, such as cholesterol, as observed in FMR1-knockout (FMR1-KO) mice and individuals with FXS [63] (Figure 2c). This evidence concerns the gene FMR1 and fragile X syndrome.